CHMP: EMA Should Clarify GMP Communications for Non-EU Drugs

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency plans to clarify its role regarding drugs manufactured in the EU solely for the export market.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor